2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Paraparesis, Tropical Spastic
1
Opportunistic Infections
1
Neuritis
1
Leukemia-Lymphoma, Adult T-Cell
1
Inflammation
1
HTLV-I Infections
1
Epstein-Barr Virus Infections
1
Cytomegalovirus Infections
1
Coinfection
1
Acquired Immunodeficiency Syndrome
1
Interventions
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
dolutegravir
1
acalabrutinib
1
Yoga
1
Tenofovir
1
Rituximab
1
Real-Time Polymerase Chain Reaction
1
Pentoxifylline
1
Massage
1
Magnetic Resonance Spectroscopy
1
Ketotifen
1
Exercise
1
Diffusion Tensor Imaging
1
Bestrophins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuritis
×
dolutegravir
×
Clear all
NCT07555431
2026-05-04
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Not yet recruiting
146 enrolled